Skip to main content
. Author manuscript; available in PMC: 2019 May 15.
Published in final edited form as: AIDS. 2018 May 15;32(8):985–997. doi: 10.1097/QAD.0000000000001778

Figure 2.

Figure 2

(A) Percent of participants using ART, and percent with suppressed viral load (HIV RNA ≤ 200 copies/mL) over time; (B) ART use expressed as percent of follow-up time accrued; (C) Mean CD4 cell count levels (± 2 SE) over time.